Haptena Therapeutics is a startup, 1 tracked investor.
Haptena Therapeutics is a startup. Brouky records 1 investor associated with the company.
Develops next-generation immunotherapies for oncogene-driven cancers by integrating precision oncology approaches with immune engineering techniques.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.